Zobrazeno 1 - 10 of 35 pro vyhledávání: '"Dhrona S"'
1
Akademický článek
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.
Autor: Meher N; National Institute of Pharmaceutical Education and Research, Lucknow, UP, India., Bidkar AP; University of California, San Francisco, San Francisco, CA, United States., Wadhwa A; University of California, San Francisco, San Francisco, CA, United States., Bobba KN; University of California, San Francisco, San Francisco, CA, United States., Dhrona S; University of California, San Francisco, San Francisco, CA, United States., Dasari C; University of California, San Francisco, San Francisco, CA, United States., Mu C; University of California, San Francisco, San Francisco, United States., Fong COY; University of California, San Francisco, San Francisco, CA, United States., Cámara JA; University of California, San Francisco, San Francisco, CA, United States., Ali U; University of California, San Francisco, San Francisco, CA, United States., Basak M; University of California, San Francisco, San Francisco, CA, United States., Bulkley D; University of California, San Francisco, San Francisco, CA, United States., Steri V; University of California, San Francisco, San Francisco, CA, United States., Fontaine SD; ProLynx Inc, San Francisco, CA, United States., Zhu J; University of California, San Francisco, San Francisco, CA, United States., Oskowitz A; University of California, San Francisco, San Francisco, CA, United States., Aggarwal RR; University of California, San Francisco, San Francisco, CA, United States., Sriram R; University of California, San Francisco, San Francisco, CA, United States., Chou J; University of California, San Francisco, San Francisco, CA, United States., Wilson DM; University of California, San Francisco, San Francisco, CA, United States., Seo Y; University of California, San Francisco, San Francisco, CA, United States., Santi DV; ProLynx, Inc., San Francisco, CA, United States., Ashley GW; ProLynx Inc, San Francisco, CA, United States., VanBrocklin HF; University of California, San Francisco, San Francisco, CA, United States., Flavell RR; University of California, San Francisco, San Francisco, CA, United States.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Zobrazit plný text záznamu
2
Akademický článek
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma.
Autor: Wadhwa A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Wang S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; School of Biomedical Engineering, ShanghaiTech University, Shanghai, China., Patiño-Escobar B; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Laboratory Medicine, University of California, San Francisco, California., Bidkar AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Bobba KN; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Chan E; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Laboratory Medicine, University of California, San Francisco, California., Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Bidlingmaier S; Department of Anesthesia, University of California, San Francisco, California., Su Y; Department of Anesthesia, University of California, San Francisco, California., Dhrona S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Geng H; Department of Laboratory Medicine, University of California, San Francisco, California., Sarin V; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Laboratory Medicine, University of California, San Francisco, California., VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., He J; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia., Zhang L; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Medicine, Department of Epidemiology and Biostatistics, University of California, San Francisco, California., Steri V; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Wong SW; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California., Martin TG; Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California., Seo Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Liu B; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Anesthesia, University of California, San Francisco, California., Wiita AP; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Laboratory Medicine, University of California, San Francisco, California.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California.; Chan Zuckerberg Biohub, San Francisco, California., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 01; Vol. 30 (5), pp. 1009-1021.
Zobrazit plný text záznamu
3
Akademický článek
Evaluation of 134 Ce/ 134 La as a PET Imaging Theranostic Pair for 225 Ac α-Radiotherapeutics.
Autor: Bobba KN; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Bidkar AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Fong C; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Wadhwa A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Dhrona S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Sorlin A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Bidlingmaier S; Department of Anesthesia, University of California, San Francisco, San Francisco, California., Shuere B; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., He J; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia; robert.flavell@ucsf.edu henry.vanbrocklin@ucsf.edu., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., Liu B; Department of Anesthesia, University of California, San Francisco, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; and., Seo Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California., VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California; robert.flavell@ucsf.edu henry.vanbrocklin@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; and., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; and.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California.
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Jul; Vol. 64 (7), pp. 1076-1082. Date of Electronic Publication: 2023 May 18.
Zobrazit plný text záznamu
4
Akademický článek
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.
Autor: Bidkar AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Wang S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Bobba KN; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Chan E; Department of Pathology, University of California, San Francisco, California., Bidlingmaier S; Department of Anesthesia, University of California, San Francisco, San Francisco, California., Egusa EA; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Peter R; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; Department of Nuclear Engineering, University of California, Berkeley, California., Ali U; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Wadhwa A; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Dhrona S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Dasari C; Department of Surgery, Cardiovascular Research Institute, University of California San Francisco, San Francisco, California., Beckford-Vera D; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Su Y; Department of Anesthesia, University of California, San Francisco, San Francisco, California., Tang R; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Zhang L; Department of Medicine and the Department of Epidemiology and Biostatistics, University of California, Berkeley, California., He J; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Aggarwal R; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Seo Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Chou J; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Liu B; Department of Anesthesia, University of California, San Francisco, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California, San Francisco, California.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 May 15; Vol. 29 (10), pp. 1916-1928.
Zobrazit plný text záznamu
5
Akademický článek
Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers.
Autor: Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States., Ashley GW; ProLynx Inc., San Francisco, California 94158, United States., Bidkar AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States., Dhrona S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States., Fong C; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States., Fontaine SD; ProLynx Inc., San Francisco, California 94158, United States., Beckford Vera DR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States., Seo Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States., Santi DV; ProLynx Inc., San Francisco, California 94158, United States., VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States.; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158-2517, United States.
Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2022 Nov 16; Vol. 14 (45), pp. 50569-50582. Date of Electronic Publication: 2022 Nov 01.
Zobrazit plný text záznamu
6
Akademický článek
Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
Autor: Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States., Seo K; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143, United States., Wang S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States., Bidkar AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States., Fogarty M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143, United States., Dhrona S; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States., Huang X; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, United States., Tang R; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States., Blaha C; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, United States., Evans MJ; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158-2517, United States., Raleigh DR; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143, United States.; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California 94143, United States., Jun YW; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158-2517, United States.; Department of Otolaryngology, University of California, San Francisco, San Francisco, California 94158, United States., VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States., Desai TA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California 94158, United States., Wilson DM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States., Ozawa T; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143, United States., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158-2517, United States.
Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Nov 24; Vol. 13 (46), pp. 54739-54752. Date of Electronic Publication: 2021 Nov 09.
Zobrazit plný text záznamu
7
Akademický článek
Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer.
Autor: Andrew, Jubilee1 (AUTHOR), Ezra-Manicum, Amanda-Lee2 (AUTHOR), Witika, Bwalya Angel1 (AUTHOR) bwalya.witika@smu.ac.za
Publikováno v: EJNMMI Radiopharmacy & Chemistry. 8/24/2024, Vol. 9 Issue 1, p1-27. 27p.
Zobrazit plný text záznamu
8
Akademický článek
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Autor: Toyohara, Jun1 (AUTHOR), Vugts, Danielle2 (AUTHOR), Kiss, Oliver C.3 (AUTHOR) o.kiss@hzdr.de, Todde, Sergio4 (AUTHOR), Li, Xiang-Guo5 (AUTHOR), Liu, Zhibo6 (AUTHOR), Yang, Zhi7 (AUTHOR), Gillings, Nic8 (AUTHOR), Cazzola, Emiliano9 (AUTHOR), Szymanski, Wiktor10 (AUTHOR), Meulen, Nick van der11 (AUTHOR), Reilly, Raymond12 (AUTHOR), Taddei, Carlotta13 (AUTHOR), Schirrmacher, Ralf14 (AUTHOR), Li, Zijing15 (AUTHOR), Lagebo, Yohannes Jorge16 (AUTHOR), Bentaleb, Naoual17 (AUTHOR), Souza Albernaz, Marta de18 (AUTHOR), Lapi, Suzanne19 (AUTHOR), Ramogida, Caterina20,21 (AUTHOR)
Publikováno v: EJNMMI Radiopharmacy & Chemistry. 5/16/2024, Vol. 9 Issue 1, p1-20. 20p.
Zobrazit plný text záznamu
9
Akademický článek
Targeted Alpha Therapy: All We Need to Know about 225 Ac's Physical Characteristics and Production as a Potential Theranostic Radionuclide.
Autor: Jalloul, Wael1,2 (AUTHOR) jalloul.wael@umfiasi.ro, Ghizdovat, Vlad1,2 (AUTHOR), Stolniceanu, Cati Raluca1,2 (AUTHOR), Ionescu, Teodor3 (AUTHOR), Grierosu, Irena Cristina1 (AUTHOR), Pavaleanu, Ioana4 (AUTHOR), Moscalu, Mihaela5 (AUTHOR), Stefanescu, Cipriana1,2 (AUTHOR)
Publikováno v: Pharmaceuticals (14248247). Dec2023, Vol. 16 Issue 12, p1679. 20p.
Zobrazit plný text záznamu
10
Akademický článek
Influence of the Molar Activity of 203/212 Pb-PSC-PEG 2 -TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake.
Autor: Pretze, Marc1 (AUTHOR) enrico.michler@ukdd.de, Michler, Enrico1 (AUTHOR) roswitha.runge@ukdd.de, Runge, Roswitha1 (AUTHOR) kerstin.wetzig@ukdd.de, Wetzig, Kerstin1 (AUTHOR) katja.tietze@ukdd.de, Tietze, Katja1 (AUTHOR) florian.brandt@ukdd.de, Brandt, Florian1 (AUTHOR) joerg.kotzerke@ukdd.de, Schultz, Michael K.2,3,4,5 (AUTHOR) mschultz@perspectivetherapeutics.com, Kotzerke, Jörg1 (AUTHOR)
Publikováno v: Pharmaceuticals (14248247). Nov2023, Vol. 16 Issue 11, p1605. 11p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje